Westpac Banking Corp’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-9,512
Closed -$241K 788
2022
Q3
$241K Hold
9,512
﹤0.01% 753
2022
Q2
$316K Hold
9,512
﹤0.01% 790
2022
Q1
$686K Hold
9,512
0.01% 742
2021
Q4
$873K Buy
9,512
+241
+3% +$28.8K 0.01% 711
2021
Q3
$1.18M Hold
9,271
0.01% 702
2021
Q2
$1.54M Sell
9,271
-25,835
-74% -$4.19M 0.02% 669
2021
Q1
$6.38M Sell
35,106
-7,449
-18% -$1.73M 0.07% 350
2020
Q4
$8.51M Buy
42,555
+37,145
+687% +$7.55M 0.1% 279
2020
Q3
$1.19M Hold
5,410
0.02% 639
2020
Q2
$1.03M Buy
+5,410
New +$948K 0.02% 630

Other funds holding TDOC

Westpac Banking Corp's TDOC Position: Q4 2022 in Review

Westpac Banking Corp sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 9,512 shares — an estimated $241K sold.

Westpac Banking Corp first reported a position in TDOC in Q2 2020 and held it in 10 quarters. The position peaked at $8.51M in Q4 2020. 443 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

  • Westpac Banking Corp reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
  • Westpac Banking Corp sold 9,512 Teladoc Health shares in Q4 2022, an estimated $241K.
  • Westpac Banking Corp first reported a position in Teladoc Health in Q2 2020 and held it in 10 quarters.
  • Westpac Banking Corp's Teladoc Health position peaked at $8.51M in Q4 2020.
  • 443 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on Westpac Banking Corp's 13F filing for Q4 2022, filed 6 Feb 2023.